Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The birth of new neurons, or neurogenesis, in the hippocampal formation has been demonstrated throughout the lifetime of multiple species including humans. A major finding in the field of depression is that treatment with antidepressant drugs increases hippocampal neurogenesis. This review presents a current summary of this field of study and presents the hypothesis that increasing adult hippocampal neurogenesis may be a new drug target or mechanism for future antidepressant drugs. It has been demonstrated that multiple classes of antidepressant drugs increase hippocampal cell proliferation and neurogenesis in a chronic and not acute time course, which corresponds to the therapeutic time course necessary for effects. Conversely, animal models of depression or stress paradigms decrease cell proliferation. Clinically, there is evidence of reduced hippocampal volume in patients with major depressive disorder or other affective disorders. Taken together, this data indicates that reduced hippocampal cell number may be involved in the pathophysiology of depression and reversal of this may be one way the antidepressant drugs exert their effects. We hypothesize that the next generation of antidepressant drugs will, in addition to their effects on known transmitter or second messenger systems, involve either direct or indirect targeting of neurogenic factors. In addition, the ability of novel compounds to be tested for the neurogenic potential may become an additional way to evaluate a compound for putative antidepressant effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The line of best fit drawn, corresponds to a Michaelis-Menten equation 65 , applied to such dose-response curves, allows derivation of values for the percentage inhibition of SERT, for different dosages of citalopram (see Figure 3 and Table 2) 61 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [61]
In the citing paper
“SSRIs are thought to produce their effect through an “initiating” step of inhibition of the serotonin transporter (SERT), leading to an increase in synaptic levels of serotonin, thereby transducing increased responses at serotonergic receptors 60,61 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [61]
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 7×
“Fluoxetine (specific serotonin reuptake inhibitor), tranylcypromine (monoamine oxidase inhibitor), reboxetine (specific norepinephrine reuptake inhibitor), imipramine (tricyclic) [50] and rolipram (phosphodiesterase-IV inhibitor hypothesized to be an antidepressant) [51] have all been shown to increase cell proliferat…”
BackgroundInfluentialAutoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592 · cited 2×
“The first reports of adult hippocampal neurogenesis in the adult rat occurred in 1965 with Altman and Das [7], followed by Kaplan and Hinds [6] in 1977.”
BackgroundMethodMore hippocampal neurons in adult mice living in an enriched environment
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1997) · Nature · doi:10.1038/386493a0 · Cited by 3,511
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Self-citationWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Degeneration and Regeneration of the Nervous System.
(1929) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1929.02710220063037 · Cited by 2,908
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853 · cited 1×
“Using retroviruses that label cells that can be identified in slice preparations, electrophysiology experiments have demonstrated that these cells are functional and send out correct synaptic connections [17].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“Chronic stress in rats downregulates BDNF in the dentate gyrus of the hippocampus, this effect is reversed by chronic antidepressant treatment [82].”
Background
Cited by
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
Czéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419
Jayatissa, M. N., Bisgaard, C., Tingström, A., Papp, M., & Wiborg, O. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301041 · Cited by 348
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318
Yoga Breathing, Meditation, and Longevity
Brown, R. P., & Gerbarg, P. L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04394.x · Cited by 282
Metadata
- Authors
- Malberg, J., & Schechter, L.
- Affiliations
- Wyeth (US)
- ORCID
- Malberg, Jessica
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-01-01
- Volume
- 11
- Issue
- 2
- Pages
- 145-155
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W1974737100
- Cited by
- 167
- References
- 101
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 13 · 2013: 7 · 2012: 8
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adult hippocampal neurogenesis, antidepressants, depression, hippocampal cell proliferation, neurogenic factors, major depressive disorder, hippocampal volume, stress, therapeutic target
- MeSH terms
- Animals, Antidepressive Agents, Chemistry, Pharmaceutical, Hippocampus, Humans, Nerve Regeneration, Neuronal Plasticity, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs. https://app.cochat.ai/papers/10.2174/1381612053382223
- The paper
- Malberg, J., & Schechter, L. (2005). Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053382223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.